Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?

The Omicron variant of SARS-CoV-2 is emerging in communities where people were previously infected with SARS-CoV-2 and are now being vaccinated, or where many people have received two or three coronavirus vaccination doses. More than 130 countries around the globe have implemented booster dose progr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavda, Vivek P., Apostolopoulos, Vasso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950261/
https://www.ncbi.nlm.nih.gov/pubmed/35334999
http://dx.doi.org/10.3390/vaccines10030367
Descripción
Sumario:The Omicron variant of SARS-CoV-2 is emerging in communities where people were previously infected with SARS-CoV-2 and are now being vaccinated, or where many people have received two or three coronavirus vaccination doses. More than 130 countries around the globe have implemented booster dose programs for tackling omicron endemics. Despite early findings shows that booster doses may improve omicron protection, more research is needed to establish vaccination efficacy. This short communication tries to critically discuss the research work findings around booster dose strategy for omicron endemics.

Ejemplares similares